Newsroom | 2159 results
Sorted by: Latest
-
Concentra Group Holdings Parent, Inc. Announces Fourth Quarter and Year Ended 2025 Results
ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation’s largest provider of occupational health services by number of locations, today announced results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter and Year Ended 2025 Highlights For the fourth quarter ended December 31, 2025: Revenue of $539.1 million, an increase of 15.9% from $465.0 million in Q4 2024 Net income of $36.2...
-
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System
GRASS LAKE, Mich.--(BUSINESS WIRE)--Blue Arbor Technologies announces $5 million investment by Ottobock to advance RESTORE™ System, designed to enable intuitive prosthetic control...
-
U.S. Physical Therapy Reports Fourth Quarter and Full Year 2025 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the fourth quarter and full year ended December 31, 2025. FINANCIAL HIGHLIGHTS Year Ended December 31, 2025 versus Year Ended December 31, 2024 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $95.0 million for...
-
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The J.P. Morgan Global Leveraged Finance Conference, being held in Miami, on Tuesday, March 3, 2026, including a fireside chat at 11:00 a.m. ET. The Leer...
-
Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Archer® Patient-Specific Instrumentation (PSI). Licensed in partnership with 3D-Side, Archer PSI is a full suite of humeral and glenoid guides tailored to the patient’s anatomy that allow orthopedic surgeons to execute their 3D p...
-
Acadia Healthcare Announces Fourth Quarter and 2025 Results
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company’s previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an...
-
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2025 Results and Provides 2026 Financial Guidance
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter Business Highlights Set patient census records for Sleep Health, Respiratory Health, and Wellness at Home, and a patient retention...
-
YARAL Pharma Prescription Topical Patches Now Available Through UpScriptHealth’s Telehealth Platform
PARSIPPANY, N.J.--(BUSINESS WIRE)--YARAL Pharma Inc. (YARAL Pharma), the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland, today announced that its prescription topical patches are now available through UpScriptHealth’s telehealth platform. This collaboration provides patients with a convenient, direct-to-consumer option to consult with a licensed clinician and obtain prescriptions online. Through its engagem...
-
OrthoCare Georgia Expands Continuum of Orthopedic CARE with New Physical Therapy Clinic in Riverdale
RIVERDALE, Ga.--(BUSINESS WIRE)--OrthoCare Georgia, the independent orthopedic practice founded by fellowship-trained orthopedic surgeon Timothy N. Ghattas, MD, has announced the opening of a new physical therapy clinic just two streets from its main Riverdale office. The addition of in-house physical therapy completes a true continuum of care—allowing patients to move from diagnosis to treatment to rehab under one coordinated, patient-first team. A key part of the launch is the return of a fam...
-
Athletes with “Never Quit” Mentality Face Increased Risk of ACL Re‑Injury
NEW YORK--(BUSINESS WIRE)--Researchers at Hospital for Special Surgery (HSS) found in a new study that athletes who report higher levels of psychological readiness to return to sport following anterior cruciate ligament (ACL) reconstruction may actually face an increased risk of re‑injury. The findings challenge long‑held assumptions about the role of psychological confidence in return‑to‑sport decisions and highlight the need for more comprehensive evaluation methods. The study was presented o...